-transparent.png){kind=logo}
Therapeutic efficacy and tolerance to long-term (2 years and longer) ambulatory administration of the new drug--ethacixin--was studied in 48 patients with various ventricular rhythm disturbances. Long-term administration of 150-200 mg of the drug daily produced a preventive effect in all those patients with ventricular rhythm disturbances, in whom it was effective during 4-7-day therapy. Ethacizin had to be discontinued in only 2 out of 48 patients because of considerable side effects.
Related Publications
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
July 1984,
Der Internist,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
January 1983,
Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
September 1986,
Kardiologiia,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
May 1987,
Kardiologiia,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
April 1983,
MMW, Munchener medizinische Wochenschrift,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
August 1982,
Der Internist,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
January 1966,
Das Deutsche Gesundheitswesen,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
November 1986,
Kardiologiia,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
May 1987,
Kardiologiia,
Kh Kh Shugushev, and
L V Rozenshtraukh, and
A S Smetnev, and
E L Ponamarenko
January 1989,
Vnitrni lekarstvi,
